Biotechnology: Class 12 — Chapter 13: Entrepreneurship

• Howard Stevenson (1983): "Entrepreneurship is the process by which individuals pursue opportunities without regard to the resources they currently control."
• Debbie Roxarzade: "Entrepreneurship is the persistent progression towards an innovative solution to a key problem. It’s the constant hunger for making things better and the idea that you are never satisfied with how things are."
• Bruce Bachenheimer: "At its core, [entrepreneurship] is a mindset – a way of thinking and acting. It is about imagining new ways to solve problems and create value."
• James Bedal: "To be a successful entrepreneur you must have a passion for learning – from customers, employees and even competitors."

Entrepreneurship serves as a primary driver for economic growth and societal development. Key contributions include:

• Capital Creation: Mobilizes and pools public resources to foster investment and wealth generation.
• Employment Generation: Creates diverse job opportunities, raising the standard of living and boosting consumer purchasing power.
• Community Development: Diversifies employment across small-scale units, promoting balanced regional growth and improving the overall quality of community life.

1. Initiative: Proactively launching ventures at the opportune moment and enduring initial developmental struggles.
2. Knowledge and Skill: Possessing deep industry insights, economic awareness, consumer preferences, and technological trends.
3. Risk Taker: Accepting long-term uncertainties and managing short-term operational risks.
4. Adaptability: Monitoring and adjusting to dynamic business environments.
5. Self-confidence: Believing in strategic decisions to catalyze risk-taking.
6. Wealth Creators: Translating innovative concepts into commercial successes that benefit both the individual and the nation.

How can scientific innovation address global public health challenges?

---

Engineering Methodology & Mechanism: Dr. Krishna Ella, Chairman and MD of Bharat Biotech International Limited (BBIL), co-founded the company in 1996 in Hyderabad. BBIL was established with support from angel investors to develop affordable vaccines. BBIL developed COVAXIN®, India's first indigenous COVID-19 vaccine, utilizing an inactivated whole-virus platform in a record time of eight months. BBIL has delivered over 4 billion vaccine doses globally, targeting diseases like Hepatitis B, Rabies, Diphtheria, and Rotavirus.

• Entrepreneur: An independent individual who takes financial and operational risks to establish a new business venture for profit.
• Intrapreneur: An employee within an existing organization who is tasked with promoting innovation, developing new product lines, or managing specialized projects using corporate resources.

• Planning: Involves setting clear objectives, defining the business model, analyzing market dynamics, outlining operational strategies, and formulating contingency plans.
• Resourcing: Focuses on securing essential inputs, including financial capital, skilled personnel, technology, raw materials, and infrastructure.

Under the Startup India Action Plan (G.S.R. notification 127 (E) dated 16 January, 2019), an entity is recognized as a startup if it meets the following criteria:

1. Incorporation Type: Incorporated as a private limited company, registered partnership firm, or limited liability partnership (LLP).
2. Turnover Limit: Annual turnover must be less than INR 100 crores in any of the previous financial years.
3. Tenure: Up to 10 years from the date of its incorporation or registration.
4. Core Objective: Working towards innovation, development, or improvement of products, services, or processes, with high potential for employment generation or wealth creation. (Entities formed by splitting up or reconstructing an existing business do not qualify).

1. Personal Investment: Self-funding by the entrepreneur to demonstrate long-term commitment to external lenders and investors.
2. Venture Capital: Institutional investment from venture capitalists targeting high-growth, technology-driven sectors (e.g., IT, Biotechnology) in exchange for equity.
3. Angel Investors: Wealthy individuals who invest capital, industry expertise, and mentorship in promising early-stage startups.
4. Business Incubators: Organizations (often linked to academic or industrial bodies) providing physical space, shared services, and developmental support, typically for a period of two years.
5. Government Grants and Subsidies: Non-dilutive financial assistance provided by state or central agencies to promote specific industrial sectors.
6. Bank Loans: Debt financing requiring a viable business plan and personal guarantees from the entrepreneur.

• Damian Hine and John Kapeleris (2006): Defined biotechnology as involving the use of living organisms or parts thereof through biological processing to develop new products or production methods.
• A.D. Meyers (2008): Described bio-entrepreneurship as the process of creating value from life science innovation, moving discoveries from the research phase to the commercial market.

1. Step 1: Need Assessment: Conducting market research to verify demand, ensuring the technology is protected by Intellectual Property (IP), and securing assets from inventors.
2. Step 2: Identification of Founders and Key Personnel: Assembling a multidisciplinary team with complementary scientific, operational, and business expertise.
3. Step 3: Getting a Legal Expert: Retaining specialized legal counsel to navigate corporate structuring, IP protection, and regulatory compliance.
4. Step 4: Incorporation as a Limited Company: Registering the startup as a Private Limited Company under the Companies Act, 2013, to accommodate high capital requirements and long gestation periods.
5. Step 5: Design a Marketing and Business Strategy: Formulating a business plan detailing the market problem, product solution, revenue generation model, and expected return on investment (ROI) to attract investors.
6. Step 6: Technology Development Focus: Prioritizing product development milestones and continuous innovation once seed capital is secured.

1. Rights of artists, painters, musicians, sculptors, photographers, and authors for copyright in their works.
2. Rights of computer programmers (source or object code) and compilation of data.
3. Rights of performers, producers of phonograms, and broadcasting organisations.
4. Right of traders in their trademarks.
5. Right of manufacturers and producers on geographical indications (GIs).
6. Right of designers for distinctive designs.
7. Right of inventors for patents of their inventions.
8. Rights of plant breeders and farmers.
9. Rights of biological diversity.
10. Right of computer technologists for layout designs of integrated circuits.
11. Right of businessmen for protection of undisclosed information (trade secrets).

• (a) Patent: Governed by the Patents Act, 1970 and Patents Rules, 1972. The 2005 Amendment deleted Section 5, allowing product patents in biotechnology, chemicals, and pharmaceuticals. Criteria for patentability: Novelty, Non-obviousness (inventive step), and Utility. Inventions must not fall under the negative list of Section 3 or be contrary to public order and morality.
• (b) Plant Breeder’s Rights and Farmer’s Variety Act: Protects new plant varieties by granting exclusive commercial rights for 20–25 years. The variety must be novel, distinct, uniform, and stable. Exceptions are made for research and traditional seed-saving by farmers.
• (c) Trademark: Governed by the Trademark Act, 1999. Defines a trademark as a mark capable of being represented graphically and distinguishing the goods or services of one entity from others. Registration requires graphical representation and distinctiveness.
• (d) Copyright: Legal protection granted to creators of literary, dramatic, musical, and artistic works. Exclusions include fair use for research, private study, criticism, review, reporting, and judicial proceedings.
• (e) Trade Secrets: Protection of confidential business information (formulas, processes, designs). In India, trade secrets are protected under contract law (NDAs) and tort law rather than dedicated legislation, in alignment with TRIPS standards.

1. The Neem Tree (Azadirachta indica): In the 1990s, W.R. Grace and Co. and the USDA obtained a patent for neem oil extraction as a pesticide. The European Patent Office (EPO) revoked the patent in 2000 following challenges demonstrating its well-documented traditional use in India.
2. Turmeric: In 1995, the University of Mississippi Medical Center was granted a U.S. patent for using turmeric powder to heal wounds. The Indian Council of Scientific and Industrial Research (CSIR) successfully challenged the patent using ancient Ayurvedic texts, leading to its revocation by the USPTO in 1997 due to lack of novelty.
3. Basmati Rice: In 1997, U.S.-based RiceTec Inc. was granted a patent by the USPTO for specific strains of Basmati rice and breeding methods. Following challenges by the Indian government regarding geographical identity and traditional agricultural knowledge, several key claims were revoked.

The TKDL is a pioneering Indian initiative designed to document traditional medicinal knowledge in a digital format. It provides international patent offices with access to historical data to prevent the misappropriation of traditional knowledge and block invalid patent applications.